We are always stand by ready for supporting our clients with expert knowledge and experiences in intellectual property. We are ready to support corporate activities by making proposals, acting flexibly at the turn of the tide, and making decisions about what to do or not to do now, and strategically advancing processes to reach solutions advantageous to our clients.
ADC Therapeutics SA (NYSE:NYSE:ADCT) Q1 2022 Earnings Conference Call May 09, 2022 08:30 AM ET Company Participants Amanda Hamilton - Investor Relations Manager Chris Martin - Former Chief.